Analytical Data
-
基因名
FLJ20449
- Application
-
别名
bHLHe81; FLJ20449; FLJ57222; SOHLH2; Solh2; SOLH2_HUMAN; SPATA28; Spermatogenesis and oogenesis specific basic helix loop helix 2; Spermatogenesis associated 28; Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2; TEB1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NX45
-
表达区间
1-425aa
-
氨基酸序列
MASSIICQEH CQISGQAKID ILLVGDVTVG YLADTVQKLF ANIAEVTITI SDTKEAAALL DDCIFNMVLL KVPSSLSAEE LEAIKLIRFG KKKNTHSLFV FIIPENFKGC ISGHGMDIAL TEPLTMEKMS NVVKYWTTCP SNTVKTENAT GPEELGLPLQ RSYSEHLGYF PTDLFACSES LRNGNGLELN ASLSEFEKNK KISLLHSSKE KLRRERIKYC CEQLRTLLPY VKGRKNDAAS VLEATVDYVK YIREKISPAV MAQITEALQS NMRFCKKQQT PIELSLPGTV MAQRENSVMS TYSPERGLQF LTNTCWNGCS TPDAESSLDE AVRVPSSSAS ENAIGDPYKT HISSAALSLN SLHTVRYYSK VTPSYDATAV TNQNISIHLP SAMPPVSKLL PRHCTSGLGQ TCTTHPNCLQ QFWAY
-
分子量
46.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the recombinant protein FLJ20449 stems from its potential implications in various biological processes and disease mechanisms. FLJ20449, initially identified through genomic sequencing projects, has been suggested to play a role in cellular functions due to its unique structural properties and expression patterns. Research has indicated that this protein may be involved in regulatory pathways and could have implications in conditions such as cancer, metabolic disorders, and immune responses. Given the rise of personalized medicine and targeted therapies, understanding the functional dynamics of FLJ20449 could unveil novel therapeutic targets or biomarkers for disease diagnosis and treatment. Furthermore, recombinant technology allows for the production of this protein in controlled laboratory settings, facilitating detailed studies on its biochemical properties, interactions with other biomolecules, and its physiological roles. Investigating FLJ20449 also contributes to the broader understanding of human proteomics, offering insights into the complexity of protein interactions and functions within the cellular environment. This makes it a significant candidate for further biological research and potential clinical applications, highlighting the importance of continued exploration into its mechanisms and effects within various physiological contexts.
